Columbus Macro LLC lifted its stake in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 7.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 340,580 shares of the company's stock after buying an additional 24,160 shares during the period. Columbus Macro LLC owned approximately 0.53% of Bain Capital Specialty Finance worth $5,654,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. CFO4Life Group LLC lifted its position in Bain Capital Specialty Finance by 2.5% in the fourth quarter. CFO4Life Group LLC now owns 31,499 shares of the company's stock valued at $552,000 after purchasing an additional 769 shares during the last quarter. Lazard Asset Management LLC raised its stake in shares of Bain Capital Specialty Finance by 14.5% during the fourth quarter. Lazard Asset Management LLC now owns 9,361 shares of the company's stock valued at $164,000 after acquiring an additional 1,189 shares during the last quarter. Comerica Bank boosted its holdings in shares of Bain Capital Specialty Finance by 8.2% during the fourth quarter. Comerica Bank now owns 17,029 shares of the company's stock worth $298,000 after purchasing an additional 1,292 shares during the period. Mascoma Wealth Management LLC bought a new stake in shares of Bain Capital Specialty Finance in the fourth quarter worth about $29,000. Finally, Advisory Services Network LLC increased its holdings in Bain Capital Specialty Finance by 16.3% during the 4th quarter. Advisory Services Network LLC now owns 12,245 shares of the company's stock valued at $215,000 after purchasing an additional 1,715 shares during the period.
Analyst Ratings Changes
Several research firms have weighed in on BCSF. Wells Fargo & Company dropped their price objective on Bain Capital Specialty Finance from $19.00 to $16.00 and set an "overweight" rating for the company in a report on Monday, April 28th. Keefe, Bruyette & Woods dropped their price target on Bain Capital Specialty Finance from $18.00 to $17.00 and set a "market perform" rating for the company in a research note on Tuesday, April 8th.
Check Out Our Latest Research Report on BCSF
Bain Capital Specialty Finance Price Performance
Shares of NYSE BCSF opened at $15.43 on Monday. Bain Capital Specialty Finance, Inc. has a 1 year low of $13.20 and a 1 year high of $19.21. The stock has a market capitalization of $1.00 billion, a P/E ratio of 7.75 and a beta of 0.80. The company's 50-day moving average is $15.26 and its 200 day moving average is $16.64. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.41 and a quick ratio of 1.41.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. The firm had revenue of $52.84 million for the quarter, compared to the consensus estimate of $71.00 million. Bain Capital Specialty Finance had a return on equity of 11.90% and a net margin of 43.62%. On average, sell-side analysts expect that Bain Capital Specialty Finance, Inc. will post 2.06 earnings per share for the current year.
Bain Capital Specialty Finance Dividend Announcement
The company also recently disclosed a dividend, which will be paid on Monday, June 30th. Shareholders of record on Tuesday, June 17th will be issued a $0.03 dividend. The ex-dividend date is Monday, June 16th. This represents a yield of 11.66%. Bain Capital Specialty Finance's dividend payout ratio (DPR) is 96.55%.
Bain Capital Specialty Finance Company Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.